Marseilles, France

Pascale Andre

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 170(Granted Patents)


Location History:

  • Marseille, FR (2015)
  • Marseilles, FR (2012 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovative Contributions of Pascale Andre in Cancer Treatment

Introduction

Pascale Andre, based in Marseilles, France, is a prolific inventor with a remarkable portfolio of 18 patents. His innovations primarily focus on advancements in cancer treatment, showcasing his commitment to improving therapeutic strategies.

Latest Patents

Among his latest patents, Pascale has developed groundbreaking methodologies in immunotherapy. One notable patent is for "Treatment regimens using anti-NKG2A antibodies," detailing methods for treating diseases, particularly cancer. This invention emphasizes the use of antibodies that bind specifically to human NKG2A, enhancing the efficacy of treatments involving these antibodies. Another significant patent, "Neutralization of inhibitory pathways in lymphocytes," explores the combination of compounds that inhibit human NKG2A and PD-1, opening new avenues for the treatment, prevention, and diagnosis of various diseases. Additionally, this invention encompasses assays for identifying tumor-infiltrating NK and/or CD8 T cells expressing NKG2A and PD-1, which is crucial for advancing targeted therapies.

Career Highlights

Pascale Andre's career has been marked by his associations with prestigious organizations. Notably, he has contributed his expertise while working with Innate Pharma, where he played a significant role in developing innovative cancer therapies. His dedication to research and innovation has established him as an influential figure in the field.

Collaborations

Throughout his career, Pascale has collaborated with esteemed colleagues such as Mathieu Blery and Alessandro Moretta. These partnerships have allowed for the exchange of ideas and have been instrumental in advancing their mutual goals in cancer research and therapy development.

Conclusion

Pascale Andre's contributions to the field of cancer treatment through his patents and collaborative efforts illustrate his dedication to innovation. With a strong focus on targeting crucial pathways in immune response, his work signifies a significant step forward in the ongoing battle against cancer. As he continues to develop new therapeutic regimens, the impact of his innovations will undoubtedly benefit patients and the broader medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…